A new research report from the Division of Global Public Health is pointing up the need for tuberculosis screening and treatment programs for injection drug users in the San Diego-Tijuana border region.Dr. Richard Garfein and his coworkers at UCSD and in Mexico have found that up to 67 percent of injection drug users in Tijuana test positive for TB infection.

This population, at risk for HIV, is vulnerable to the dangerous combination in which an HIV-weakened immune system allows a latent TB infection to become active.

Read the full story
from UCSD News

The data come from Proyecto el Cuete, a collaborative study that includes researchers from UC San Diego and two institutions in Tijuana.Principal investigator in the study is Richard Garfein, Ph.D., M.P.H., Associate Adjunct Professor of Medicine in the Division of Global Public Health.

Other Department of Medicine investigators in the study are Steffanie Strathdee, Ph.D., Professor and Chief of the Division of Global Public Health and Associate Dean of Global Health Sciences; and Antonino Catanzaro, M.D., Professor in the Division of Pulmonary and Critical Care Medicine.

The report is released in the May issue of the International Journal of Tuberculosis and Lung Disease.

More Information


%d bloggers like this: